A phase 1 trial of BHV-1510
Latest Information Update: 16 Jan 2024
At a glance
- Drugs BHV 1510 (Primary)
- Indications Carcinoma; Tumours
- Focus Therapeutic Use
Most Recent Events
- 16 Jan 2024 New trial record
- 08 Jan 2024 According to a Biohaven media release, the company plans to initate this trial in in 2Q 2024.